a b s t r a c t A recent publication by Mekonnen et al. demonstrated that among women with non-obstructive coronary artery disease, higher levels of circulating progenitor cells in the blood (CPC), were associated with impaired coronary flow reserve [1].
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A recent publication by Mekonnen et al. demonstrated that among women with non-obstructive coronary artery disease, higher levels of circulating progenitor cells in the blood (CPC), were associated with impaired coronary flow reserve [1] .
We performed a quality control assessment of the stability of circulating blood progenitor cells in blood samples stored at 4°C, to determine the time period during which blood samples can be analyzed and yield consistent data for progenitor cell content. Healthy volunteers (n ¼6) were recruited and underwent phlebotomy, and blood was stored in EDTA tubes at 4°C. Flow cytometry was performed to quantitate progenitor cell subsets at 0-4 h, 24 h, and 48 h post phlebotomy. All processed samples were fixed with 1% Paraformaldehyde and 1,000,000 total data events were collected. We found no significant differences in PC data for both CD34 þ (P ¼0.68 for one-way ANOVA) and CD34þ /CD133þ (P¼ 0.74 for one-way ANOVA Multiple samples collected during one day can be analyzed in a batch the following day, thus increasing the efficiency of laboratory personnel analyzing samples.
Data
Progenitor cell content for CD34 þ /CD45 dim , CD34 þ/CD133þ/CD45 dim , subsets in 300 uL aliquots of anticoagulated blood were measured by flow cytometry. Triplicate aliquots of blood from each sample were analyzed at each time point, and the mean values for each time point for every subject were calculated to determine the stability of the progenitor cell content during storage (Fig. 1) . The standardized mean values for the 0-4 h time point was used as the baseline, and the relative change of mean values for the subsequent time points was calculated as a percentage of the baseline value. We found no significant differences in PC counts for both CD34 þ ( Fig. 1 Panel A, P ¼0.68) and CD34 þ/CD133þ (Fig. 1 Panel B , P ¼0.74).
Experimental design, materials and methods
Gently mix by inversion and reverse pipet 300 ul blood sample to a 5 ml FACS tube. Add antibody cocktail to blood sample and vortex and incubate in the dark for 15 min. Add 1.2 ml Ammonium chloride lysis buffer, vortex and incubate in the dark for 10 min. Sample should become relatively transparent post lysis. Add 1.2 ml staining media the add 350 ul 1% paraformaldehyde to fix cells, seal the tubes with parafilm and mix gently by inverting several times. Store samples at 4°C. Before acquisition on the FACS Canto II, reverse pipet 100 ul Invitrogen counting beads to the prepared samples, mixed gently and run. FCS files we a're analyzed in FlowJo version 9.8.5. Staining Media-1X PBS 485 mL. 15 mL FBS. 0.5 g of Sodium azide (NaN3). Combine and store at 4°C.
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